Table 3 Serum cytokines/chemokines (n = 36).

From: Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis

Cytokine/chemokines, median [IQR]

Total

Poor

Good

Serum RANTES, pg/mL

117,300 (59,515–201,368)

97,290 (38,634–185,167)

141,428 (67,840–209,952)

Serum Fractalkine, pg/mL

77.2 (4.2–130.6)

87.4 (0–230)

67.5 (16.7–116.5)

Serum IFN-γ, pg/mL

6.9 (1.5–17.6)

7.4 (1.4–12.7)

4.5 (1.7–25.2)

Serum IL-10, pg/mL

0.07 (0–17.90)

0 (0–19.5)

2.71 (0–18.9)

Serum IL-4, pg/mL

0 (0–0)

0 (0–0)

0 (0–3.76)

Serum IL-6, pg/mL

2.8 (0–43.3)

1.1 (0–59.3)

10.1 (0.9–40.3)

Serum MCP-1, pg/mL

626 (324–852)

571 (271–872)

632 (376–850)

Serum TNF-α, pg/mL

37 (19–65)

35 (18–74)

37 (19–53)

Serum VEGF, pg/mL

284 (127–564)

220 (105–865)

330 (141–547)

Serum BLC, pg/mL

162 (97–256)

104 (68–227)

162 (106–294)

  1. Variables are shown as median (interquartile range).
  2. BLC, B lymphocyte chemokine; IFN, interferon; IFTA, interstitial fibrosis tubular atrophy; IL, interleukin; IQR, interquartile range; MCP, monocyte chemoattractant protein; RANTES, regulated on activation, normal T cell expressed and secreted; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.